Production and characterization of vaccines based on flaviviruses defective in replication
about
Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon ProductionInduction of Epitope-Specific Neutralizing Antibodies against West Nile VirusProduction of Pseudoinfectious Yellow Fever Virus with a Two-Component GenomeConstruction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genesIdentification of Mutated Cyclization Sequences That Permit Efficient Replication of West Nile Virus Genomes: Use in Safer Propagation of a Novel Vaccine CandidatePredictive spatial models for risk of West Nile virus exposure in eastern and western ColoradoConstruction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2Helices 2 and 3 of West Nile Virus Capsid Protein Are Dispensable for Assembly of Infectious VirionsExtension of Flavivirus Protein C Differentially Affects Early RNA Synthesis and Growth in Mammalian and Arthropod Host CellsEfficient, trans-complementing packaging systems for chimeric, pseudoinfectious dengue 2/yellow fever virusesSynergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal deliveryModulation of innate immune signaling by the secreted form of the West Nile virus NS1 glycoproteinEvaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.A new model to produce infectious hepatitis C virus without the replication requirement.Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitisIntrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.Single-dose vaccine against tick-borne encephalitis.TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidateWest Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles.Reverse Genetics Approaches to Control Arenavirus.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.RNA-based viral vectors.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation.The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses.Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine.Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets.The amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains.Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus.
P2860
Q27481032-C739CD48-FF27-458F-A32D-BBD88B537A82Q27484980-9FCDCED7-CC6F-4F40-AD38-C64EE3C7688EQ27484992-03560243-6924-4E30-B109-1E24766DE9A2Q27485041-0367F482-11E3-43AA-99B1-1AFDDD13F2C4Q27486407-09E2C58B-B7D1-4087-B46E-E079B3B18891Q27487329-7977A9BB-A509-403E-814C-622AFFD43CD1Q27487946-6FE5D908-68DE-4188-889E-EF0E30D741D2Q27488390-D00F92C8-C241-444C-8181-2DE86A4AC207Q27490326-26BC3F52-B13C-4C47-9EF0-6AB65D066D09Q27491035-EB61FBA2-6D96-4D83-A258-B2483D029E43Q33576050-EF106BB9-C356-4B8A-B5D9-BA357CD2C78DQ33584872-0168F8B3-D85C-4854-BFC2-26E9EE1E493CQ33821633-70DF47DE-9343-41D3-A343-76BCF2CF04C3Q33880730-B3F045C5-B639-4640-8C75-0F587F993E0BQ33886707-65CB6A8E-339B-48C9-B713-AC6240ACDB8BQ33972018-FED61E15-D1C0-4E3F-A54C-9658FCECE1E6Q34053031-75118E0F-61DA-429B-ABFF-461ABE652FC0Q35742553-8ACCA2EE-08BD-4D5E-B266-FC1D81B32FF2Q37088625-2A032945-0259-4774-87E6-DB450A57CA6DQ37254256-B361496A-5955-4EAD-A243-4C8808E8CD6EQ37336383-B4544EFA-4CAB-44F6-B5ED-F7746DD3A33AQ37543755-D594201D-5283-41D8-8211-6F0CFC3AF517Q37842337-59963AA3-3E02-4478-BC97-B4E2D4B2292FQ38266413-479E7958-00D7-4898-9A37-C8240D021CB9Q38866173-B40C2788-53E5-4108-BF60-E3CDAC1C4C0DQ39230468-FE3E7E7D-8403-45FB-8CAF-4DA72E6D158FQ40208169-32E2F5AE-0C0F-4DF3-8100-CC2431BF0035Q40218664-79170DF6-C528-467F-8E1E-2424BD15539FQ41218531-D3EF250D-B080-483A-A725-DF7D3C11E9E8Q41934776-1982759A-699C-469A-8B67-1A825A22876AQ42272083-8DE29B70-9FFC-493C-A3EF-F533384AD221Q42977902-74E786A9-B848-423D-9159-9947CCBDA0BD
P2860
Production and characterization of vaccines based on flaviviruses defective in replication
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Production and characterizatio ...... ruses defective in replication
@ast
Production and characterizatio ...... ruses defective in replication
@en
Production and characterizatio ...... ruses defective in replication
@nl
type
label
Production and characterizatio ...... ruses defective in replication
@ast
Production and characterizatio ...... ruses defective in replication
@en
Production and characterizatio ...... ruses defective in replication
@nl
prefLabel
Production and characterizatio ...... ruses defective in replication
@ast
Production and characterizatio ...... ruses defective in replication
@en
Production and characterizatio ...... ruses defective in replication
@nl
P2860
P1433
P1476
Production and characterizatio ...... ruses defective in replication
@en
P2093
Peter W Mason
P2860
P304
P356
10.1016/J.VIROL.2006.04.003
P407
P577
2006-05-18T00:00:00Z